UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Annals of oncology, 2012-08, Vol.23 (8), p.1979-1985

2012

Volltextzugriff (PDF)

Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability

Drug metabolism and disposition, 1995-12, Vol.23 (12), p.1315

1995

Volltextzugriff (PDF)

Update in the pharmaceutical therapy of the irritable bowel syndrome

International journal of clinical practice (Esher), 2004-04, Vol.58 (4), p.374-381

2004

Volltextzugriff (PDF)

3004 POSTER DISCUSSION Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase ll/lll Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone

European journal of cancer (1990), 2011, Vol.47, p.S223-S223

2011

Volltextzugriff (PDF)

Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber

British journal of pharmacology, 1996-04, Vol.117 (8), p.1730-1734

1996

Volltextzugriff (PDF)

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment

The European respiratory journal, 2008-07, Vol.32 (1), p.139-146

2008

Volltextzugriff (PDF)

Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients

Clinical chemistry (Baltimore, Md.), 1996-09, Vol.42 (9), p.1426-1432

1996

Volltextzugriff (PDF)

Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ

Respiratory research, 2009-07, Vol.10 (1), p.65-65, Article 65

2009

Volltextzugriff (PDF)

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Results from the German competence network CAPNETZ

Intensive care medicine, 2007-12, Vol.33 (12), p.2069-2078

2007

Volltextzugriff (PDF)

Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ

Clinica chimica acta, 2010-12, Vol.411 (23-24), p.1929-1934

2010

Volltextzugriff (PDF)

C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia—influence of antibiotic pre-treatment: results from the German competence network CAPNETZ

Journal of antimicrobial chemotherapy, 2009-07, Vol.64 (1), p.159-162

2009

Volltextzugriff (PDF)

Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.‐MS and microparticle enzyme immunoassay (MEIA)

British journal of clinical pharmacology, 1994-12, Vol.38 (6), p.567-571

1994

Volltextzugriff (PDF)

Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay

Therapeutic drug monitoring, 1995-10, Vol.17 (5), p.504-510

1995

Volltextzugriff (PDF)

Quality-of-life assessment in patients with malignant ascites: Results of a multicenter phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.9113-9113

2011

Volltextzugriff (PDF)

Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation

Therapeutic drug monitoring, 1996-12, Vol.18 (6), p.640-646

1996

Volltextzugriff (PDF)

Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry

Naunyn-Schmiedeberg's archives of pharmacology, 1996-03, Vol.353 (4), p.461-473

1996

Volltextzugriff (PDF)

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Annals of oncology, 2012-08, Vol.23 (8), p.1979

2012

Volltextzugriff (PDF)

PCN67 MANAGEMENT OF MALIGNANT ASCITES IN GERMANY—TREATMENT PATTERNS, RESOURCE CONSUMPTION, AND COSTS

Value in health, 2010, Vol.13 (7), p.A263-A263

2010

Volltextzugriff (PDF)

Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Geburtshilfe und Frauenheilkunde, 2012, Vol.72 (4)

2012

Volltextzugriff (PDF)

136 TACROLIMUS (FK506) METABOLITE PATTERNS IN BLOOD FROM LIVER AND KIDNEY TRANSPLANT PATIENTS

Therapeutic drug monitoring, 1995-08, Vol.17 (4), p.417

1995

Volltextzugriff (PDF)

190 EVALUATION OF THE NEW PRO-TRACR TACROLIMUS MONOCLONAL WHOLE BLOOD ELISA FOR MONITORING OF TACROLIMUS LEVELS IN PATIENTS AFTER KIDNEY, HEART AND LIVER TRANSPLANT

Therapeutic drug monitoring, 1995-08, Vol.17 (4), p.430

1995

Volltextzugriff (PDF)

Simplified high-performance liquid chromatrography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay

Therapeutic drug monitoring, 1995, Vol.17 (5), p.504-510

1995

Volltextzugriff (PDF)

Super-Resolution Imaging of Tight and Adherens Junctions: Challenges and Open Questions

International journal of molecular sciences, 2020-01, Vol.21 (3), p.744

2020

Volltextzugriff (PDF)

Nanoscale segregation of channel and barrier claudins enables paracellular ion flux

Nature communications, 2022-08, Vol.13 (1), p.4985-4985, Article 4985

2022

Volltextzugriff (PDF)

Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting

Clinical therapeutics, 2014-12, Vol.36 (12), p.2015-2028.e2

2014

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(101)
Deutsch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability

Update in the pharmaceutical therapy of the irritable bowel syndrome

3004 POSTER DISCUSSION Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase ll/lll Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone

Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment

Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients

Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Results from the German competence network CAPNETZ

Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ

C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia—influence of antibiotic pre-treatment: results from the German competence network CAPNETZ

Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.‐MS and microparticle enzyme immunoassay (MEIA)

Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay

Quality-of-life assessment in patients with malignant ascites: Results of a multicenter phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation

Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

PCN67 MANAGEMENT OF MALIGNANT ASCITES IN GERMANY—TREATMENT PATTERNS, RESOURCE CONSUMPTION, AND COSTS

Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

136 TACROLIMUS (FK506) METABOLITE PATTERNS IN BLOOD FROM LIVER AND KIDNEY TRANSPLANT PATIENTS

190 EVALUATION OF THE NEW PRO-TRACR TACROLIMUS MONOCLONAL WHOLE BLOOD ELISA FOR MONITORING OF TACROLIMUS LEVELS IN PATIENTS AFTER KIDNEY, HEART AND LIVER TRANSPLANT

Simplified high-performance liquid chromatrography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay

Super-Resolution Imaging of Tight and Adherens Junctions: Challenges and Open Questions

Nanoscale segregation of channel and barrier claudins enables paracellular ion flux

Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting

Suchergebnisse filtern